Exome Asset Management as of June 30, 2024
Portfolio Holdings for Exome Asset Management
Exome Asset Management holds 50 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 7.6 | $8.8M | 9.7k | 905.38 | |
| Merus N V (MRUS) | 5.9 | $6.8M | 74k | 91.78 | |
| Sarepta Therapeutics (SRPT) | 4.5 | $5.2M | 33k | 158.00 | |
| Tg Therapeutics (TGTX) | 3.9 | $4.5M | 252k | 17.79 | |
| Wave Life Sciences SHS (WVE) | 3.8 | $4.4M | 497k | 8.87 | |
| Cigna Corp (CI) | 3.5 | $4.0M | 12k | 330.57 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 3.3 | $3.8M | 85k | 45.25 | |
| Insmed Com Par $.01 (INSM) | 3.3 | $3.8M | 57k | 67.00 | |
| Amgen (AMGN) | 3.2 | $3.7M | 12k | 312.45 | |
| Travere Therapeutics (TVTX) | 3.2 | $3.6M | 443k | 8.22 | |
| Madrigal Pharmaceuticals (MDGL) | 2.6 | $3.0M | 11k | 280.16 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 2.6 | $2.9M | 209k | 14.06 | |
| Dex (DXCM) | 2.6 | $2.9M | 26k | 113.38 | |
| Autolus Therapeutics Spon Ads (AUTL) | 2.5 | $2.9M | 840k | 3.48 | |
| Intuitive Surgical Com New (ISRG) | 2.5 | $2.8M | 6.4k | 444.85 | |
| Dr Reddys Labs Adr (RDY) | 2.4 | $2.8M | 36k | 76.19 | |
| Disc Medicine (IRON) | 2.4 | $2.7M | 61k | 45.07 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.4 | $2.7M | 20k | 136.38 | |
| Kura Oncology (KURA) | 2.4 | $2.7M | 132k | 20.59 | |
| Biohaven (BHVN) | 2.2 | $2.5M | 90k | 28.16 | |
| Masimo Corporation (MASI) | 2.2 | $2.5M | 20k | 125.94 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.2 | $2.5M | 275k | 9.03 | |
| Guardant Health (GH) | 2.0 | $2.3M | 79k | 28.88 | |
| Cabaletta Bio (CABA) | 2.0 | $2.2M | 300k | 7.48 | |
| Arvinas Ord (ARVN) | 1.9 | $2.2M | 82k | 26.62 | |
| Natera (NTRA) | 1.8 | $2.0M | 19k | 108.29 | |
| Bridgebio Pharma (BBIO) | 1.7 | $2.0M | 79k | 25.33 | |
| Fulcrum Therapeutics (FULC) | 1.6 | $1.9M | 303k | 6.20 | |
| Apellis Pharmaceuticals (APLS) | 1.6 | $1.8M | 47k | 38.36 | |
| Alphatec Hldgs Com New (ATEC) | 1.5 | $1.7M | 162k | 10.45 | |
| Establishment Labs Holdings Ord (ESTA) | 1.4 | $1.6M | 26k | 61.52 | |
| Abcellera Biologics (ABCL) | 1.3 | $1.5M | 515k | 2.96 | |
| Zai Lab Adr (ZLAB) | 1.3 | $1.5M | 87k | 17.33 | |
| Pliant Therapeutics (PLRX) | 1.2 | $1.3M | 124k | 10.75 | |
| Rezolute Com New (RZLT) | 1.1 | $1.2M | 282k | 4.30 | |
| Alvotech Ordinary Shares (ALVO) | 1.0 | $1.2M | 99k | 12.16 | |
| Gossamer Bio (GOSS) | 0.9 | $1.0M | 1.1M | 0.90 | |
| Elevation Oncology (ELEV) | 0.9 | $997k | 369k | 2.70 | |
| Procaps Group Sa SHS (PROC) | 0.8 | $877k | 129k | 6.79 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.7 | $821k | 159k | 5.16 | |
| Quanterix Ord (QTRX) | 0.7 | $788k | 60k | 13.21 | |
| Q32 Bio (QTTB) | 0.7 | $787k | 44k | 17.95 | |
| Vyne Therapeutics (VYNE) | 0.6 | $696k | 353k | 1.97 | |
| Pmv Pharmaceuticals (PMVP) | 0.5 | $581k | 358k | 1.62 | |
| Aprea Therapeutics Com New (APRE) | 0.5 | $558k | 137k | 4.07 | |
| Adagene Ads (ADAG) | 0.4 | $462k | 151k | 3.06 | |
| I Mab Sponsored Ads (IMAB) | 0.4 | $453k | 271k | 1.67 | |
| Hillevax (HLVX) | 0.2 | $260k | 18k | 14.46 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.2 | $173k | 51k | 3.42 | |
| Pacific Biosciences of California (PACB) | 0.1 | $103k | 75k | 1.37 |
